SCHEMBL20847736

SCHEMBL20847736

Cc1ncccc1C1=CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 6/20 0.50
SIGMAR1 Q99720 1/20 0.47
CDK9 P50750 3/20 0.45
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
DRD2 P14416 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HTR6 P50406 6/20 0.44
CCNT1 O60563 2/20 0.43
HTR2A P28223 2/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
RAD52 P43351 1/20 0.42
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
PDE10A Q9Y233 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24196984 0.84 HTR2C (0.50) HTR2CSIGMAR1CDK9KDM4EALDH1A1
SCHEMBL18278895 0.81 HTR2C (0.50) HTR2CSIGMAR1CDK9KDM4EALDH1A1
SCHEMBL20598454 0.80 HTR2C (0.46) HTR2CSIGMAR1CDK9KDM4EALDH1A1
SCHEMBL4004663 0.77 SIGMAR1 (0.47) HTR2CSIGMAR1CDK9KDM4EALDH1A1
Hydrochloric Acid SCHEMBL3790021 0.76 HTR2C (0.49) HTR2CSIGMAR1CDK9KDM4EALDH1A1
Hydrochloric Acid SCHEMBL9530706 0.76 HTR2C (0.61) HTR2CSIGMAR1KDM4EALDH1A1MAPT
SCHEMBL1366798 0.76 HTR2C (0.61) HTR2CSIGMAR1KDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL15006828 0.75 HTR2C (0.55) HTR2CSIGMAR1KDM4EALDH1A1MAPT
SCHEMBL38661232 0.75 HTR2C (0.49) HTR2CSIGMAR1CDK9KDM4EALDH1A1
SCHEMBL12537881 0.75 L3MBTL1 (0.45) HTR2CSIGMAR1CDK9DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3164395-B1 INDANE AND INDOLINE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS NOVARTIS AG (CH) 2019-03-27 EP disclosed